From the *Faculty of Medicine, University of New South Wales, Kensington, Australia; †Sexual Health and Blood Borne Virus Unit, Department of Health, Northern Territory, Australia; ‡Sydney Sexual Health Centre, South East Sydney and Illawarra Area Health, Sydney, Australia; §School of Public Health and Community Medicine, University of New South Wales, Kensington, Australia; and ¶The Kirby Institute, University of New South Wales, Kensington, Australia
Correspondence: Benjamin Kwan, MBBS, University of New South Wales, Sydney, Australia. E-mail: email@example.com.
Received for publication November 25, 2011, and accepted December 28, 2011.
Background: Men are recommended to not urinate for at least 1 hour before urine testing for Chlamydia trachomatis, but some studies have shown that recent urination does not impact test sensitivity for nucleic acid amplification tests. The objective of this study was to estimate the sensitivity of chlamydia testing using samples obtained 20-minutes post void.
Methods: We recruited men returning to Sydney Sexual Health Centre for treatment of urethral Chlamydia trachomatis infection between July 2009 and February 2011. A short questionnaire was used to elicit symptoms, and 2 first-void urine samples were collected—the first after the standard 1 hour minimum and the second 20 minutes later. Men with clinical or microbiologic evidence of urethritis, men receiving antibiotic treatment, and those who had urinated within the last hour were excluded. Samples were tested using Roche COBAS Amplicor PCR. The proportion of samples testing positive at 20 minutes post void was determined using the 1-hour post void sample as a gold standard.
Results: Thirty-one men with confirmed chlamydia infection were included in the analysis. Of these, 29 of 31 (93.5%) were positive at 20 minutes (95% CI: 78.6%–99.2%).
Conclusions: The sensitivity of 20-minute voiding intervals in asymptomatic men remains reasonably high relative to standard voiding intervals. Removing the barrier of a 1-hour voiding interval should be considered during opportunistic screening.
The widespread availability of highly sensitive nucleic acid amplification tests (NAATs) allows convenient and noninvasive screening for Chlamydia trachomatis. NAAT manufacturer instructions specify a minimum voiding interval of 1 or 2 hours before submitting urine for testing (Amplicor, Roche; Probetec, Becton and Dickinson Company; product information). However, these recommendations are not based on any real evidence and may constitute an additional barrier to screening uptake in men.1 Previous studies in predominantly symptomatic men have found no difference in NAAT sensitivity with voiding intervals less than the recommended minimum.2–4
The aim of this study was to estimate the sensitivity of 20-minute voiding intervals in men without symptomatic urethritis using the standard 1-hour post void as a gold standard.
MATERIALS AND METHODS
Men recalled to Sydney Sexual Health Centre during the period from July 15, 2009 to February 1, 2011 for treatment of laboratory-confirmed urethral C. trachomatis infection were invited to participate in the study if they attended at a time when a study nurse was on-site. Men who were diagnosed with nongonococcal urethritis (>5 polymorphonuclear leukocytes/high-power field in at least 3 fields) or with obvious clinical signs of urethritis and treated at the test visit were excluded from the study. Urethral Gram stain was only performed in the presence of urethral symptoms or signs.
A short questionnaire was used at the recall visit to determine whether participants had held their urine for at least 1 hour, had taken any antibiotics, or developed any minor urethral symptoms since their initial positive C. trachomatis test. Two first void urine samples were collected, the first at more than 1 hour since last void, and the second 20 minutes later. An electronic timer was used to alert men when 20 minutes had elapsed. Men were excluded if they had urinated in the last hour, had received chlamydia treatment, were unable to provide timely and adequate samples, or unable to read written instructions in English. All urine samples were stored and transported at 4°C. All samples reached the laboratory within 4 hours and were tested within 48 hours using the Roche COBAS Amplicor CT/NG PCR assay (Roche Molecular Diagnostics, Basel, Switzerland).
A power calculation was performed using OpenEpi version 2.3; a sample size of 30 would be required, with 80% likelihood, to detect a 10% difference in the proportion testing positive, assuming a sensitivity of 90% for the 20-minute post void sample. This interval was considered to fall within the reported sensitivity range of the assay.5 The sensitivity of 20-minute voiding intervals was assessed using the 1-hour post void sample as a gold standard, and 95% confidence intervals calculated using binomial distribution.
Informed consent was obtained from all participants, and the study was approved by the Human Research Ethics Committee of South Eastern Sydney Illawarra Area Health Service.
Over the study period, 366 men were diagnosed with urethral C. trachomatis at Sydney Sexual Health Centre. Of these, 113 were eligible men with no evidence of symptomatic urethritis and had not received any chlamydia treatment, and returned during the study period. Forty-seven (41.5%) men were invited to participate. A total of 37 (37 of 113 eligible, 32.7%) men consented to participate in the study. At the study visit, five participants tested negative for C. trachomatis on both specimens, and one was unable to produce a 20-minute sample. Subsequently, 31 pairs of first void urine samples were tested and included in data analysis.
The median age of participants included in the analysis was 26 years. Thirty-one men had positive initial samples. Of these 31, 29 (93.5%) were also positive at 20 minutes (95% CI: 78.6%–99.2%), whereas 2 men were negative. Of the 5 men who tested negative on the 1-hour sample, 2 had received antibiotics, 1 amoxicillin, and 1 ceftriaxone.
Previous studies have reported that NAAT test sensitivity for C. trachomatis is not affected by voiding intervals below the recommended minimum.2–4 Using the APTIMA Combo 2 assay, Matthew et al.4 demonstrated that samples obtained at least 20 minutes after recent urination were equally sensitive to standard 1-hour intervals. However, their sample consisted mostly of symptomatic men, whereas the current study recruited men without clinical or microbiologic evidence of urethritis. Asymptomatic men have a demonstrably lower organism load,6 and therefore a greater likelihood for reductions in test sensitivity with shorter voiding intervals. Also, comparisons of the Amplicor CT/NG assay and the APTIMA Combo 2 have shown the latter to be more sensitive in the detection of C. trachomatis.7 This may explain why in our study, 20-minute voiding intervals were associated with a high, although slightly reduced, sensitivity relative to standard intervals.
A limitation of the current study was the low number of eligible men recruited. The recruitment rate was fairly low (47 of 113; 41.5%), as this depended on the availability of a study nurse at the time eligible participants reattended. None of the men reported symptoms, nor were any symptoms documented in their medical records; however, the study questionnaire elicited minor urethral symptoms in ten of the men.
One screening study based in a family planning clinic found the most common reason for exclusion from chlamydia screening was having voided in the last hour, with as many as 14% of the survey population excluded for this reason.1 Using the reported prevalence of urethral chlamydia of 4.5% in heterosexual men and 8.7% in men who have sex with men,8,9 the negative predictive value of 20-minute samples can be calculated to exceed 99%. As the aim of an opportunistic screening program is the early detection of cases in the population, not total exclusion of infection in those tested, our findings suggest patients should not be excluded from opportunistic testing if they have recently voided. The greater uptake in opportunistic testing achieved by removing the 1 to 2 hour minimum voiding interval is likely to offset the small loss in sensitivity that may occur with shorter voiding intervals.
1. Sparrow M, Lewis H, Brown P, et al.. Chlamydia screening in Wellington Family Planning Association (FPA) clinics: A demonstration project. N Z Med J 2007; 120:U2490.
2. Chernesky M, Jang D, Chong S, et al.. Impact of urine collection order on the ability of assays to identify Chlamydia trachomatis infections in men. Sex Transm Dis 2003; 30:345–347.
3. Manavi K, Young H. The significance of voiding interval before testing urine samples for Chlamydia trachomatis in men. Sex Transm Infect 2006; 82:34–36.
4. Matthew T, O'Mahony C, Mallinson H. Shortening the voiding interval for men having Chlamydia nucleic acid amplification tests. Int J STD AIDS 2009; 20:752–753.
6. Michel CE, Sonnex C, Carne CA, et al.. Chlamydia trachomatis load at matched anatomic sites: Implications for screening strategies. J Clin Microbiol 2007; 45:1395–1402.
7. Lowe P, O'Loughlin P, Evans K, et al.. Comparison of the Gen-Probe APTIMA Combo 2 assay to the AMPLICOR CT/NG assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine samples from Australian men and women. J Clin Microbiol 2006; 44:2619–2621.
8. Kong FY, Hocking JS, Link CK, et al.. Sex and sport: Chlamydia screening in rural sporting clubs. BMC Infect Dis 2009; 27:73.
9. Jin F, Prestage GP, Mao L, et al.. Incidence and risk factors for urethral and anal gonorrhoea and chlamydia in a cohort of HIV-negative homosexual men: The Health in Men Study. Sex Transm Infect 2007; 83:113–119.